BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15381190)

  • 1. Comparative genomic analysis of Pseudomonas aeruginosa virulence.
    Woods DE
    Trends Microbiol; 2004 Oct; 12(10):437-9. PubMed ID: 15381190
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic islands of Pseudomonas aeruginosa.
    Battle SE; Rello J; Hauser AR
    FEMS Microbiol Lett; 2009 Jan; 290(1):70-8. PubMed ID: 19025565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic analysis of Pseudomonas aeruginosa PA96, the host of carbapenem resistance plasmid pOZ176.
    Déraspe M; Alexander DC; Xiong J; Ma JH; Low DE; Jamieson FB; Roy PH
    FEMS Microbiol Lett; 2014 Jul; 356(2):212-6. PubMed ID: 24673340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico comparison of pKLC102-like genomic islands of Pseudomonas aeruginosa.
    Würdemann D; Tümmler B
    FEMS Microbiol Lett; 2007 Oct; 275(2):244-9. PubMed ID: 17714478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
    Finnan S; Morrissey JP; O'Gara F; Boyd EF
    J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid pathogenicity island PAGI-5 contributes to the highly virulent phenotype of a Pseudomonas aeruginosa isolate in mammals.
    Battle SE; Meyer F; Rello J; Kung VL; Hauser AR
    J Bacteriol; 2008 Nov; 190(21):7130-40. PubMed ID: 18757543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspects of Pseudomonas aeruginosa opportunism].
    Falcone G; Garzelli C; Serra MC
    G Batteriol Virol Immunol; 1979; 72(1-6):62-71. PubMed ID: 121983
    [No Abstract]   [Full Text] [Related]  

  • 8. Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates.
    Shen K; Sayeed S; Antalis P; Gladitz J; Ahmed A; Dice B; Janto B; Dopico R; Keefe R; Hayes J; Johnson S; Yu S; Ehrlich N; Jocz J; Kropp L; Wong R; Wadowsky RM; Slifkin M; Preston RA; Erdos G; Post JC; Ehrlich GD; Hu FZ
    Infect Immun; 2006 Sep; 74(9):5272-83. PubMed ID: 16926421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterization indicates that a specific subpopulation of Pseudomonas aeruginosa is associated with keratitis infections.
    Stewart RM; Wiehlmann L; Ashelford KE; Preston SJ; Frimmersdorf E; Campbell BJ; Neal TJ; Hall N; Tuft S; Kaye SB; Winstanley C
    J Clin Microbiol; 2011 Mar; 49(3):993-1003. PubMed ID: 21227987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in the composition of the accessory genome of Mexican Pseudomonas aeruginosa strains.
    Espinosa-Camacho LF; Delgado G; Cravioto A; Morales-Espinosa R
    Genes Genomics; 2022 Jan; 44(1):53-77. PubMed ID: 34410625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CrpP, a passenger or a hidden stowaway in the Pseudomonas aeruginosa genome?
    Ruiz J
    J Antimicrob Chemother; 2019 Nov; 74(11):3397-3399. PubMed ID: 31335936
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of regulatory networks in Pseudomonas aeruginosa by genomewide transcriptional profiling.
    Goodman AL; Lory S
    Curr Opin Microbiol; 2004 Feb; 7(1):39-44. PubMed ID: 15036138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of rhamnolipids by Pseudomonas aeruginosa.
    Soberón-Chávez G; Lépine F; Déziel E
    Appl Microbiol Biotechnol; 2005 Oct; 68(6):718-25. PubMed ID: 16160828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis.
    Kipnis E; Sawa T; Wiener-Kronish J
    Med Mal Infect; 2006 Feb; 36(2):78-91. PubMed ID: 16427231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa.
    Wolfgang MC; Kulasekara BR; Liang X; Boyd D; Wu K; Yang Q; Miyada CG; Lory S
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8484-9. PubMed ID: 12815109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico.
    Garza-Ramos U; Tinoco P; Silva-Sanchez J; Morfin-Otero R; Rodriguez-Noriega E; Leon-Garnica G; Sader HS; Jones RN
    Int J Antimicrob Agents; 2008 Jan; 31(1):78-80. PubMed ID: 17913472
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa.
    Boşgelmez-Tinaz G; Ulusoy S
    Microb Pathog; 2008 Jan; 44(1):13-9. PubMed ID: 17689222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines.
    Stepińska M; Trafny EA
    Microb Pathog; 2008 May; 44(5):448-58. PubMed ID: 18221854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISPa20 advances the individual evolution of Pseudomonas aeruginosa clone C subclone C13 strains isolated from cystic fibrosis patients by insertional mutagenesis and genomic rearrangements.
    Kresse AU; Blöcker H; Römling U
    Arch Microbiol; 2006 May; 185(4):245-54. PubMed ID: 16474952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rearrangement of a large novel Pseudomonas aeruginosa gene island in strains isolated from a patient developing ventilator-associated pneumonia.
    Singh G; Srinivasan R; Cheng J; Peng Z; Fujimura K; Baek MS; Panzer AR; Tringe SG; Chen F; Sorek R; Weng L; Bristow J; Wiener-Kronish JP; Lynch SV
    J Clin Microbiol; 2014 Jul; 52(7):2430-8. PubMed ID: 24789195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.